Akèy › Metiyè › Biochemists and Biophysicists › Waltham, MA

Biochemists and Biophysicists nan Waltham, MA: Salè H-1B

125 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Waltham, MA. Salè baz medyàn ofri $107,099; mwatye mitan $84,005–$126,000.

Demann (LCA)125

Salè medyan ofri$107,099

Mwatye salè yo$84,005–$126,000

10yèm–90yèm pousantaj$63,120–$143,894

Pa nivo salè

Nivo revni	Salè medyan
Nivo I (antre)	$85,000
Nivo II (kalifye)	$115,815
Nivo III (eksperyans)	$126,305
Nivo IV (plen kompetans)	$146,120

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

Anplwayè	LCA	Salè medyan
Brandeis University	22	$61,578
Visterra, Inc.	12	$151,500
Sanofi Pasteur Inc.	11	$108,410
AstraZeneca Pharmaceuticals LP	11	$132,924
Sanofi US Services Inc.	9	$107,099
Dragonfly Therapeutics, Inc.	7	$126,000
Dyne Therapeutics, Inc.	7	$123,000
Biocytogen Boston Corp.	5	$95,000
Howard Hughes Medical Institute	4	$80,000
TScan Therapeutics, Inc.	4	$75,000
Sanofi Vaccines US Inc.	4	$101,026
Northway Biotech Inc	3	$101,026
Affinia Therapeutics, Inc.	2	$91,838
Lumicks USA, Inc.	2	$102,326
Apogee Therapeutics, Inc.	2	$118,331
Yoh, A Day & Zimmermann Company	2	$95,514
Quantum Diamond Technologies Inc.	2	$123,000
Seqirus Inc.	2	$123,600
DynamiCure Biotechnology LLC	1	$88,605
Arrakis Therapeutics, Inc.	1	$120,000
Exosome Diagnostics, Inc.	1	$96,242
Resilience US, Inc.	1	$115,000
Palleon Pharmaceuticals Inc.	1	$90,000
enGene USA Inc.	1	$155,000
Alloy Therapeutics, Inc.	1	$157,000
BrickBio Inc.	1	$126,610
Alkermes, Inc.	1	$146,120
Snapdragon Chemistry, Inc.	1	$90,480
Mythic Therapeutics, Inc.	1	$87,966
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$140,000
AbbVie Bioresearch Center Inc.	1	$88,680
Amide Technologies, Inc.	1	$135,000

Tit travay

Pwonse H-1B nan Waltham, MA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).